Overview Poniard Pharmaceuticals is currently conducting clinical trials of intravenous picoplatin, including a Phase 3 trial in small cell lung cancer and two Phase 2 trials, in metastatic colorectal and hormone-refractory prostate cancers. A Phase 1 clinical trial of oral picoplatin in patients with solid tumors is also ongoing. Small Cell Lung Cancer (SCLC) Colorectal Cancer Prostate Cancer Patients and Physicians: For more information about the studies in small cell lung cancer, colorectal cancer or hormone-refractory prostate cancer, or to find a study location near you, please call 1-888-879-7007 or email clinicaltrials@poniard.com.